Assessment of Tumor Blood Flow Distribution by Dynamic Contrast-Enhanced CT

A distinct feature of the tumor vasculature is its tortuosity and irregular branching of vessels, which can translate to a wider dispersion and higher variability of blood flow in the tumor. To enable tumor blood flow variability to be assessed in vivo by imaging, a tracer kinetic model that accounts for flow dispersion is developed for use with dynamic contrast-enhanced (DCE) CT. The proposed model adopts a multiple-pathway approach and allows for the quantification of relative dispersion in the blood flow distribution, which reflects flow variability in the tumor vasculature. Monte Carlo simulation experiments were performed to study the possibility of reducing the number of model parameters based on the Akaike information criterion approach and to explore possible noise and tissue conditions in which the model might be applicable. The model was used for region-of-interest analysis and to generate perfusion parameter maps for three patient DCE CT cases with cerebral tumors, to illustrate clinical applicability.

[1]  G. Brix,et al.  Simulation-based comparison of two approaches frequently used for dynamic contrast-enhanced MRI , 2010, European Radiology.

[2]  E H Wood,et al.  Applications of the Lagged Normal Density Curve as a Model for Arterial Dilution Curves , 1966, Circulation research.

[3]  Ting-Yim Lee,et al.  Dynamic, contrast-enhanced CT of human brain tumors: quantitative assessment of blood volume, blood flow, and microvascular permeability: report of two cases. , 2002, AJNR. American journal of neuroradiology.

[4]  Lucy E Kershaw,et al.  Temporal resolution and SNR requirements for accurate DCE‐MRI data analysis using the AATH model , 2010, Magnetic resonance in medicine.

[5]  Gary M. Raymond,et al.  Modeling blood flow heterogeneity , 1996, Annals of Biomedical Engineering.

[6]  T-Y Lee,et al.  CT imaging of angiogenesis. , 2003, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[7]  David R. Anderson,et al.  Model Selection and Multimodel Inference , 2003 .

[8]  M. P. Hayball,et al.  Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography , 2012, European Radiology.

[9]  S. Sourbron,et al.  A comparison of tracer kinetic models for T1‐weighted dynamic contrast‐enhanced MRI: Application in carcinoma of the cervix , 2010, Magnetic resonance in medicine.

[10]  Michael Jerosch-Herold,et al.  Direct comparison of an intravascular and an extracellular contrast agent for quantification of myocardial perfusion , 1999, The International Journal of Cardiac Imaging.

[11]  K. Zierler,et al.  On the theory of the indicator-dilution method for measurement of blood flow and volume. , 1954, Journal of applied physiology.

[12]  Tong San Koh,et al.  Dynamic contrast-enhanced CT of intracranial meningioma: comparison of distributed and compartmental tracer kinetic models--initial results. , 2004, Radiology.

[13]  P. Choyke,et al.  Imaging of angiogenesis: from microscope to clinic , 2003, Nature Medicine.

[14]  D. Drost,et al.  Simultaneous MRI measurement of blood flow, blood volume, and capillary permeability in mammary tumors using two different contrast agents , 2000, Journal of magnetic resonance imaging : JMRI.

[15]  Fabian Kiessling,et al.  Estimation of tissue perfusion by dynamic contrast-enhanced imaging: simulation-based evaluation of the steepest slope method , 2010, European Radiology.

[16]  T S Koh,et al.  The inclusion of capillary distribution in the adiabatic tissue homogeneity model of blood flow. , 2001, Physics in medicine and biology.

[17]  Tong San Koh,et al.  A distributed parameter model of cerebral blood-tissue exchange with account of capillary transit time distribution , 2006, NeuroImage.

[18]  C. Thng,et al.  Fundamentals of tracer kinetics for dynamic contrast‐enhanced MRI , 2011, Journal of magnetic resonance imaging : JMRI.

[19]  J. Bassingthwaighte,et al.  Modeling regional myocardial flows from residue functions of an intravascular indicator. , 1996, The American journal of physiology.

[20]  T S Koh,et al.  Issues of discontinuity in the impulse residue function for deconvolution analysis of dynamic contrast‐enhanced MRI data , 2011, Magnetic resonance in medicine.

[21]  K. Zierler Equations for Measuring Blood Flow by External Monitoring of Radioisotopes , 1965, Circulation research.

[22]  Minsong Cao,et al.  Functional imaging in small animals using X-ray computed Tomography -study of physiologic measurement reproducibility , 2005, IEEE Transactions on Medical Imaging.

[23]  G. Brix,et al.  Tracer kinetic modelling of tumour angiogenesis based on dynamic contrast-enhanced CT and MRI measurements , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[24]  M. Bahner,et al.  Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CT--initial experience. , 1999, Radiology.

[25]  Matthias C. Schabel A unified impulse response model for DCE‐MRI , 2012, Magnetic resonance in medicine.

[26]  D. Balvay,et al.  Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment , 2006, Abdominal Imaging.